Well, it is a time of great uncertainty for RVX.

Completion of BoM is now delayed to 2019 with no explanation.

There is uncertainty of the timing of the FA. I believe if the FA fails RVX will probably continue as a company but probably within a new ownership structure. Someone will want the IP which still could result in leading edge science.

I wonder that if the FA fails but the safety profile remains good RVX could elect to still continue with the trial if they can get funding?

If the Hepalink financing is approved we then will have an RVX which is 43% owned by Hepalink and with only enough money to continue BoM for a few months. My guess is that Hepa will demand more representation on the board.

I suppose, as one poster has pointed out, it might be possible for RVX to trundle along quarter by quarter doing PPs and gradually fragmenting or concentrating the share structure until, perhaps, some investor steps in and picks up this company for some price far below "what should be" it's price currently (e.g.$6+). For example Hepa just did it (once approved).

If the Hepa financing passes and the FA passes then Don better have the winning ace card in his hand to fund BoM and other trials as well as balancing the share structure.

If Don does not already have a licensing deal already locked up contingent on passing the FA then perhaps he'll go back to suitors and try to attract some suitor independent of Hepa (which may not have the funds to take over RVX).

IMO I have not seen any evidence that Don has his act together (of course I realize the confidentialty and secrecy required in such a deal). Add to this the scientific uncertainty (delay in FA) and the complete lack of explanations for changes such as in the timing of BoM results, etc it sure has me scratching my head.

I'm not selling my shares. There is no point at this stage and I am still betting on a scientific breakthrough.

Finally I realize science is always a process of discovery characterized by great uncertainty. Also, clinical trials are complex processes and change should also be expected. 

My real frustration is that Don is not providing good management in that he could show us enough respect to provide explanations.

GLTA

Toinv